TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Radiographic (X-Ray) Union at Week 30
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of Treatment-Emergent Adverse Events at Week 30
Endpoint domain: Adverse events/effects
Primary endpoint: early tumour relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Weighted PCV20 vaccine effectiveness against Invasive Pneumococcal Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Weighted PCV20 vaccine effectiveness against Pneumococcal Pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Weighted PCV20 vaccine effectiveness against all cause pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Overall response rate (ORR) per RECIST v1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of solicited systemic events
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of at least one adverse event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Homeostasis model assessment- insulin resistance (HOMA-IR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: QLQ C-30 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hospitalization/death
Endpoint domain: Mortality/survival
Primary endpoint: Visualization of papilla
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: I-FABP (intestinal fatty acid binding protein) to measure epithelial wall injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Claudin to measure tight junction leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LBP (lipopolysaccharide binding protein) to measure endotoxin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Quality of Life Level
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from Baseline in Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Mean total Sequential Organ Failure Assessment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of COVID-19 related hospitalizations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COVID-19 related ICU admissions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COVID-19 related deaths
Endpoint domain: Mortality/survival
Primary endpoint: VAF1 - variance accounted for in a single muscle activation module
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: walkDMC - walking Dynamic Motor Control Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood lipid components
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change of asthma control test (score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of asthma exacerbations (number)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of use of systemic steroids (number)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Female sexual function scale (FSFI)
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Sexual Life Quality Scale- Female
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Circulating tumor DNA (ctDNA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: level of serum 25(OH) vitamin D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: level of osteocalcin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in reported anxiety related symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Brain development assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Level of 25-hydroxycholecalciferol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of subjects with overall success at Day 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of serum neurofilament light protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Family Satisfaction in the Intensive Care Unit
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: YBOCS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in prostate cancer (PCa) progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in maximal oxygen uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in oxygen consumption and oxygen cost
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in the respiratory exchange ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Simple Endoscopic Score for Crohn's disease (SES-CD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pharmacokinetic parameters of Infliximab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of tattoo particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distribution of tattoo particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cytokine storm occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ultrasonographic diaphragm function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in Karolinska Sleepiness Scale (KSS) scores before and after drug administration
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Difference of RVESVi by CMR from baseline to 12 months follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of asymptomatic malaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of symptomatic malaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of spontaneous abortions or intrauterine deaths
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Proportion of fetal morbidities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Proportion of neonatal and early neonatal mortality
Endpoint domain: Mortality/survival
Primary endpoint: Unified Parkinson's disease rating Scale (UPDRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Montreal Cognitive Assessment Scale (MoCA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: King's Parkinson's Pain Assessment (KPPS)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: PD Sleep Scale (PDSS)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Activities of daily living Assessment - Barthel
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Striatal BOLD response to reward outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amygdala BOLD response to emotional stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GABA neurotransmitter level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neural activity and connectivity strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF-MPQ (Short-Form McGill Pain Questionnaire)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Goniometer (Range of Motion Measurement)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Negative diagnosis of CE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in administration of surgical antibiotic prophylaxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Scanning time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of proximal contacts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of occlusal contacts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contact lens dry eye symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative amount of ICG administrated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Dose of ICG administrated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants detected to have cardiac arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peri-implant soft tissue esthetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Study Imaging Agent-Associated Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: rate of preterm birth of infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Apgar score of infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: body weight of infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: head circumference of infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Polyneuropathy-severity of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quality of life score-(EORTC QLQ-C30)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Central Sensitization Inventory score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Geometric Mean Titers (GMT) of SARS-CoV-2 Antibody Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in level of T-cell response after mRNA COVID-19 vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of participants with detectable level of T-cell response after mRNA COVID-19 vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Methadone treatment adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platform usability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in concentration of short-chain fatty acids and other metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Composite event of HCV-related or HCV treatment-related death, fibrosing cholestatic hepatitis, or HCV relapse
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants with liver injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Assessment of disease severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants who Complete at least 90% of Study Follow-ups
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time Required to Complete Enrolment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: bucco-palatal width of the alveolar socket
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Visual analgesic scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall survival (OS1)
Endpoint domain: Mortality/survival
Primary endpoint: Overall survival (OS 2)
Endpoint domain: Mortality/survival
Primary endpoint: Mean relative wound area reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subject Outcome Variable
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Study Drug-related adverse events (SDAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment-Emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Difference in IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of improvement in functional outcome
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changed BASDAI score >2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline caries status in enamel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Change from Baseline caries status in dentine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: percentage of subjects with complications related to the device
Endpoint domain: Adverse events/effects
Primary endpoint: Viral clearance of SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Sensory integration disorders and relapses in the last year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of disease severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NOL Index variation (Delta-NOL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the appearance/clearing of atopic dermatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of target Lesion Failure (TLF) at 12 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of NACEs
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of daily median intracranial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in nutrition as measured by the Mediterranean Diet 14-Item Screener Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Falciparum malaria incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Falciparum malaria prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Overall percentage of falciparum malaria positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Female Sexual Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual pain analogic scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rates of en-bloc resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Overall Survival at 5 years
Endpoint domain: Mortality/survival
Primary endpoint: Video Hand Opening Time (VHOT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor Function Measures (MFM-32)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical effectiveness of endovascular exclusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Locoregional Recurrence-Free Survival Time
Endpoint domain: Mortality/survival
Primary endpoint: Total pain rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score in landing error scoring system test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of knee injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in serum iPTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Maximum change in blood pressure (SBP and DBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: The area under effect-time curve (AUEC0- 4h) of supine systolic (SBP) and diastolic (DBP) blood pressure, and pulse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of procedure and device related serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with successful chronic ventricular pacing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement of health literacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain: Numerical Pain Scale (NPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life: SF12 Health Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maximum joint force moment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rate of change of acne scars appearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: MRF pain at rest and with cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morphological identification of Blastocystis hominis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: change in blood pressure measurement skill score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in Blood Pressure Measurement Knowledge score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Perioperative incidence of cardiopulmonary complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lubricin levels in serum and synovial fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survivin levels in serum and synovial fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MSUS findings on involved joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pelvic tilt angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lumbar arrow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cervical arrow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anteroposterior trunk flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Air particle count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary System Information Test Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cell-associated HIV RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Chronic kidney disease hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of Participants with Vital Sign Abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Number of hospital interventions from new-liver related complications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Decreased hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Lack of Objective Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity measured by NRS Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of specific T cell responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants with Major Bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Recurrent VTE
Endpoint domain: Adverse events/effects
Primary endpoint: N-back task performance (reaction time and % of correct)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Forward and Backward digit span
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Wisconsin card sorting test (WCST)
Endpoint domain: Cognitive functioning
Primary endpoint: Change in Simon task
Endpoint domain: Cognitive functioning
Primary endpoint: Change in Visual-spatial working memory span measured by Corsi Block-Tapping task
Endpoint domain: Cognitive functioning
Primary endpoint: Overall Disability Response Score (ODRS) at Week 48
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cmax of hydrochlorothiazide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast of hydrochlorothiazide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Color stability assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expulsion Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure Difference between front and rear ends of Fecobionics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes